Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1434.95 | 2953.00 | 4319.25 | 0.6837 | 0.5745 |
BT-20 | Linsitinib | 10 | uM | 9 | 2500.00 | 1434.95 | 3149.00 | 4319.25 | 0.7291 | 0.6395 |
BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4242.00 | 4319.25 | 0.9821 | 0.9774 | |
BT-20 | Lapatinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3962.00 | 4319.25 | 0.9173 | 0.8943 |
BT-20 | Lapatinib | 10 | uM | 9 | 2500.00 | 1434.95 | 1420.00 | 4319.25 | 0.3288 | -0.0066 |
BT-20 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4482.00 | 4319.25 | 1.0377 | 1.0471 |
BT-20 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4382.00 | 4319.25 | 1.0145 | 1.0182 |
BT-20 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4334.00 | 4319.25 | 1.0034 | 1.0043 |
BT-20 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 1395.00 | 4319.25 | 0.3230 | -0.0176 |
BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4269.00 | 4319.25 | 0.9884 | 0.9853 | |
BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7204.00 | 7094.50 | 1.0154 | 1.0230 | |
BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7309.00 | 7094.50 | 1.0302 | 1.0451 | |
BT-20 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7530.00 | 7094.50 | 1.0614 | 1.0911 |
BT-20 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 2808.68 | 7577.00 | 7094.50 | 1.0680 | 1.1009 |
BT-20 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 2808.68 | 7664.00 | 7094.50 | 1.0803 | 1.1189 |
BT-20 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 6644.00 | 7094.50 | 0.9365 | 0.9042 |
BT-20 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 4339.00 | 7094.50 | 0.6116 | 0.3845 |
BT-20 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7371.00 | 7094.50 | 1.0390 | 1.0580 |
BT-20 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 2808.68 | 7194.00 | 7094.50 | 1.0140 | 1.0209 |
BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7274.00 | 7094.50 | 1.0253 | 1.0377 | |
BT-20 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 2808.68 | 2601.00 | 7094.50 | 0.3666 | -0.0558 |
BT-20 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7261.00 | 7094.50 | 1.0235 | 1.0350 |
BT-20 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 7187.00 | 7094.50 | 1.0130 | 1.0195 |
BT-20 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 6789.00 | 7094.50 | 0.9569 | 0.9352 |
BT-20 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7069.00 | 7094.50 | 0.9964 | 0.9946 |